Biocide Use in the Antimicrobial Era: A Review
dc.contributor.author | Jones, IA | |
dc.contributor.author | joshi, lovleen | |
dc.date.accessioned | 2021-04-18T15:36:01Z | |
dc.date.available | 2021-04-18T15:36:01Z | |
dc.date.issued | 2021-04-14 | |
dc.identifier.issn | 1420-3049 | |
dc.identifier.issn | 1420-3049 | |
dc.identifier.other | ARTN 2276 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/17052 | |
dc.description.abstract |
<jats:p>Biocides are widely used in healthcare and industry to control infections and microbial contamination. Ineffectual disinfection of surfaces and inappropriate use of biocides can result in the survival of microorganisms such as bacteria and viruses on inanimate surfaces, often contributing to the transmission of infectious agents. Biocidal disinfectants employ varying modes of action to kill microorganisms, ranging from oxidization to solubilizing lipids. This review considers the main biocides used within healthcare and industry environments and highlights their modes of action, efficacy and relevance to disinfection of pathogenic bacteria. This information is vital for rational use and development of biocides in an era where microorganisms are becoming resistant to chemical antimicrobial agents.</jats:p> | |
dc.format.extent | 2276-2276 | |
dc.format.medium | Electronic | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | MDPI | |
dc.subject | biocides | |
dc.subject | bacteria | |
dc.subject | antibiotic | |
dc.subject | antimicrobial | |
dc.subject | disinfection | |
dc.subject | surfaces | |
dc.subject | transmission | |
dc.subject | chemical | |
dc.subject | resistance | |
dc.title | Biocide Use in the Antimicrobial Era: A Review | |
dc.type | journal-article | |
dc.type | Journal Article | |
dc.type | Review | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000644611100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.issue | 8 | |
plymouth.volume | 26 | |
plymouth.publication-status | Published online | |
plymouth.journal | Molecules | |
dc.identifier.doi | 10.3390/molecules26082276 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/School of Biomedical Sciences | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
dc.publisher.place | Switzerland | |
dcterms.dateAccepted | 2021-04-06 | |
dc.rights.embargodate | 2021-4-20 | |
dc.identifier.eissn | 1420-3049 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.3390/molecules26082276 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2021-04-14 | |
rioxxterms.type | Journal Article/Review |